Viewing nowCombinationDuoWell Plus Tablet 40/10/10 mg
Telmisartan 40mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation

MFDS item code 202106634 · Approved 2021.09.24 · Insurance code 642105840
Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular disease
This medication is used for patients who need to take telmisartan and rosuvastatin/ezetimibe simultaneously. Telmisartan is effective in the treatment of essential hypertension and helps reduce the risk of myocardial infarction, stroke, and cardiovascular disease death in high-risk cardiovascular disease patients aged 55 years or older, in whom ACE inhibitors are not suitable. Rosuvastatin and ezetimibe improve cholesterol and related lipid levels in patients with primary hypercholesterolemia or mixed dyslipidemia. This combination medication is used for the reduction of cardiovascular disease risk and improvement of blood lipids.
This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of telmisartan and the rosuvastatin/ezetimibe combination. Take 1 tablet once daily with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). ○ Telmisartan 1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Telmisartan has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of telmisartan is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting telmisartan to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. • Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin/ezetimibe The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended starting dose is 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. The dose may be increased to a maximum of 20/10mg once daily. Patients taking telmisartan and the rosuvastatin/ezetimibe combination concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Muscle-related side effects can occur rarely, especially if acute myalgia or rhabdomyolysis is suspected; treatment should be stopped immediately and medical attention sought. This medication should not be administered to patients with severely impaired liver and kidney function; caution should be exercised in patients with a history of liver or kidney disease. Patients with certain genetic diseases, such as lactose intolerance, should not receive this medication. It can lower blood pressure; therefore, symptoms of hypotension may occur, particularly in patients with low blood volume, requiring more caution. This medication can elevate liver enzyme levels; it is necessary to perform regular liver function tests before and during administration. There is a risk of developing hyperkalemia; blood potassium levels should be checked regularly, and particularly careful observation is needed for patients with risk factors. Interactions may occur when used with other medications, so it is essential to inform the doctor or pharmacist of any other medications being taken. Dizziness or drowsiness may occur while driving or operating dangerous machinery, so caution is advised. Rarely, serious skin reactions or severe muscle weakness may occur; immediate consultation with medical personnel is warranted if a rash or muscle weakness symptoms appear. Routine blood tests and health status checks during the course of this medication are important to monitor for adverse reactions.
Increase in ALT, increase in AST, increase in Ɣ-GTP, increase in ALP, abdominal pain, oral ulcers, vomiting, chest pain, palpitations, dizziness, shortness of breath, functional abnormalities of the Eustachian tube, tympanic membrane perforation, acute kidney injury, hematuria, herpes zoster, pneumonia, non-small cell lung cancer, hair loss, dysuria, rhinitis, discomfort in the oropharynx, pulmonary disease, unspecified intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, chest pain, facial swelling, unusual sensations, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, drowsiness, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes mellitus, impaired glucose tolerance, depression, bronchitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, liver toxicity, acute hepatitis, toxic hepatitis, increase in gamma-glutamyl transferase, increase in blood cholesterol, increase in serum alkaline phosphatase, irregular heart rate, osteoarthritis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, sweating, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory disorders, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, upper respiratory infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, abdominal pain, diarrhea, dyspepsia, abdominal distension, abdominal discomfort, dry mouth, liver function abnormalities, liver disease, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthritis pain, limb pain, tendon pain, acute renal failure, weakness, influenza-like illness, increased serum creatinine, elevated serum uric acid, increased serum creatine kinase, decreased hemoglobin, shock, syncope due to hypotension, loss of consciousness, jaundice, anaphylactic-like symptoms, interstitial pneumonia, rhabdomyolysis, palpitations, fatigue, nausea, lack of effect, headache, facial spasms, sensory disturbances, paralysis, cough, hyperventilation, flushing, erectile dysfunction, loss of appetite, edema, decreased libido, facial edema, rash, alopecia, conjunctivitis, noises in the ear, petechiae, polyneuropathy, memory loss, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lupus-like syndrome, muscle rupture, joint pain, immune-mediated necrotizing myopathy, hematuria, edema, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscle weakness, oculobulbar weakness, chest discomfort, loss of appetite, abdominal distention, abnormal liver function tests, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to keep it at room temperature between 1 and 30 degrees Celsius. This way, the efficacy of the medication can be maintained for a longer period.
Pink oval film-coated tablet
30 tablets/box [6 tablets/PTP X 5]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg +1 more
Tablet · Prescription medication · Combination
Green Cross Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg +1 more
Tablet · Prescription medication · Combination
(Co., Ltd.) Green Cross
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.